(1)
Disphanurat, W. .; Srisantithum, B. . Efficacy and Safety of 0.15% Isobutylamido Thiazolyl Resorcinol Combined With Hyaluronic Acid Versus 0.15% Isobutylamido Thiazolyl Resorcinol or Hyaluronic Acid Alone in Melasma Treatment: A Randomized Evaluator-Blind Trial. AMJAM 2022, 22, S117.